A phase II trial of ifosfamide/mesna with doxorubicin for malignant mesothelioma.
Carmichael
J
J
University Department of Clinical Oncology, Newcastle General Hospital, U.K.
Cantwell
B M
BM
Harris
A L
AL
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004317:Doxorubicin / Q000008:administration & dosage; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008297:Male; D015080:Mesna / Q000008:administration & dosage; D008654:Mesothelioma / Q000188:drug therapy*; D008875:Middle Aged; D010997:Pleural Neoplasms / Q000188:drug therapy
D004317:Doxorubicin; D015080:Mesna; D007069:Ifosfamide